（日本語訳版）医療機器GMLP 10の指針原則（by FDA, Health Canada and MHRA）：「GAMP 5 2nd Edition, Appendix D11(AI/ML)からも参照」 2023.01.29
（中・日・英語版）1_Announcement of NMPA on Direct Reporting of ADRs by Drug MHA (No. [2018] 66)_C_J_E.pdf 2022.06.28
（中・日・英語版）2_Guidelines for the Collection and Reporting of Individual Adverse Drug Reactions_C_J_E 2022.06.27
（中・日・英語版）3_Standards and Procedures for Expedited Reporting of Safety Data during Drug Clinical Trials_C_J_E 2022.06.26
